Lorazepam Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Lorazepam Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 05/03/2018. Reported reason: Demand increase for the drug
Shortage Details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 65219-368-02
- Dosage Form
- Injection
- Presentation
- Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02)
- Initial Posting
- 05/03/2018
- Revised Date
Reason
Demand increase for the drug